Literature DB >> 18840719

Tregitopes switch on Tregs.

Rachel R Caspi1.   

Abstract

Year:  2008        PMID： 18840719      PMCID： PMC2569158          DOI： 10.1182/blood-2008-08-173609

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  5 in total

1.  Intravenous immunoglobulin therapy affects T regulatory cells by increasing their suppressive function.

Authors:  Aharon Kessel; Hana Ammuri; Regina Peri; Elsa R Pavlotzky; Miri Blank; Yehuda Shoenfeld; Elias Toubi
Journal:  J Immunol       Date:  2007-10-15       Impact factor: 5.422

Review 2.  Anti-inflammatory actions of intravenous immunoglobulin.

Authors:  Falk Nimmerjahn; Jeffrey V Ravetch
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

Review 3.  Recombinant immunoglobulin-based epitope delivery: a novel class of autoimmune regulators.

Authors:  William J Phillips; Dan J Smith; Constantin A Bona; Adrian Bot; Habib Zaghouani
Journal:  Int Rev Immunol       Date:  2005 Sep-Dec       Impact factor: 5.311

4.  Epitope-specific tolerance induction with an engineered immunoglobulin.

Authors:  E T Zambidis; D W Scott
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

5.  Expansion of CD4+CD25+ regulatory T cells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalomyelitis.

Authors:  Amal Ephrem; Souleima Chamat; Catherine Miquel; Sylvain Fisson; Luc Mouthon; Giuseppina Caligiuri; Sandrine Delignat; Sriramulu Elluru; Jagadeesh Bayry; Sebastien Lacroix-Desmazes; José L Cohen; Benoît L Salomon; Michel D Kazatchkine; Srini V Kaveri; Namita Misra
Journal:  Blood       Date:  2007-10-11       Impact factor: 22.113
  5 in total
  4 in total

Review 1.  Immunomodulation by intravenous immunoglobulin: role of regulatory T cells.

Authors:  Mohan S Maddur; Shivashankar Othy; Pushpa Hegde; Janakiraman Vani; Sébastien Lacroix-Desmazes; Jagadeesh Bayry; Srini V Kaveri
Journal:  J Clin Immunol       Date:  2010-05       Impact factor: 8.317

Review 2.  Tregs and infections: on the potential value of modifying their function.

Authors:  Sharvan Sehrawat; Barry T Rouse
Journal:  J Leukoc Biol       Date:  2011-09-13       Impact factor: 4.962

Review 3.  Diabetes tolerogenic vaccines targeting antigen-specific inflammation.

Authors:  Shuang Geng; Huiyuan Zhang; Xian Zhou; Yue He; Xiaoqian Zhang; Xiaoping Xie; Chaofan Li; Zhonghuai He; Qingling Yu; Yiwei Zhong; Douglas B Lowrie; Guoxing Zheng; Bin Wang
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

4.  Saccharomyces cerevisiae as a model organism: a comparative study.

Authors:  Hiren Karathia; Ester Vilaprinyo; Albert Sorribas; Rui Alves
Journal:  PLoS One       Date:  2011-02-02       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.